Primary Care Model for Cancer Survivorship
(EPICS Trial)

Recruiting in Palo Alto (17 mi)

+12 other locations

Overseen byErin E. Hahn, PhD, MPH

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Kaiser Permanente

No Placebo Group

Trial Summary

What is the purpose of this trial?

A quasi-experimental non-randomized pre/post with control group trial of two models of cancer survivorship care in early-stage colorectal and breast cancer survivors cared for in a community-based, integrated health care setting.

Research Team

Erin E. Hahn, PhD, MPH

Principal Investigator

Kaiser Permanente Southern California, Department of Research & Evaluation

Eligibility Criteria

The EPICS Study is for adult members of Kaiser Permanente Southern California who have been treated for early-stage breast or colorectal cancer within the last 6-36 months. They must be at low risk for recurrence, able to complete surveys in English or Spanish, and have had an oncology visit. High-risk patients and those under 21 are excluded.

Inclusion Criteria

Completed at least one office visit within Kaiser Permanente Southern California medical oncology.

Physicians: For centers assigned to the embedded primary care physician (PCP) model, PCPs selected to participate must be Board Certified in a relevant primary care specialty; hold a valid and current MD or advanced practitioner license; and be employed by the Southern California Permanente Medical Group.

My primary language is either English or Spanish.

See 4 more

Exclusion Criteria

I am at high risk of my cancer returning and experiencing side effects from treatment.

I am under 21 years old.

Treatment Details

Interventions

Embedded primary care in cancer survivorship model (Behavioural Intervention)

Trial OverviewThis study tests a new model where primary care is integrated into the follow-up process for cancer survivors. It compares outcomes before and after implementing this model among people who've survived early-stage breast or colorectal cancer.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ConditionExperimental Treatment1 Intervention

The trial will test the efficacy of an embedded primary care provider (PCP) model (experimental condition) in which PCPs are trained in survivorship and then embedded within an oncology practice to care for low-risk, early stage breast and colorectal cancer survivors who will be transitioned at 6-36 months post-treatment for comprehensive survivorship care.

Group II: Control ConditionActive Control1 Intervention

Usual care for breast and colorectal cancer survivors (oncology-led model).